Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
50.9 USD | +3.33% | +13.62% | +162.64% |
Mar. 22 | North American Morning Briefing : Stocks Struggle After New Records | DJ |
Mar. 21 | William Blair Initiates Neurogene With Outperform Rating | MT |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 654M |
---|---|---|---|---|---|
Net income 2024 * | -61M | Net income 2025 * | -76M | EV / Sales 2024 * | - |
Net cash position 2024 * | 327M | Net cash position 2025 * | 501M | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-13.6
x | P/E ratio 2025 * |
-13.5
x | Employees | 91 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 86.64% |
Latest transcript on Neurogene Inc.
1 day | +3.33% | ||
1 week | +13.62% | ||
Current month | +63.82% | ||
1 month | +56.91% | ||
3 months | +221.74% | ||
Current year | +162.64% |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 50.9 | +3.33% | 411 713 |
24-03-27 | 49.26 | -0.38% | 139,979 |
24-03-26 | 49.45 | +0.86% | 80,599 |
24-03-25 | 49.03 | -1.70% | 211,713 |
24-03-22 | 49.88 | +1.34% | 215,801 |
Delayed Quote Nasdaq, March 28, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+162.64% | 633M | |
+9.30% | 45.97B | |
+52.73% | 43.93B | |
+7.15% | 42.34B | |
-8.78% | 28.27B | |
+18.68% | 27.18B | |
-21.92% | 19.44B | |
+14.62% | 13.83B | |
+31.85% | 12.4B | |
+4.47% | 11.45B |